# Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

> **NCT06309212** · — · COMPLETED · sponsor: **Acibadem University** · enrollment: 2197 (actual)

## Conditions studied

- The Prevalance of HMPV After COVID-19 Pandemic
- The Importance of Accurate Diagnosis for HPMV

## Interventions

- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT06309212
- **Lead sponsor:** Acibadem University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-15
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-01-30
- **Target enrollment:** 2197 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309212, "Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06309212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*